E-Mail
New cutting-edge research undertaken at the University of Leicester could revolutionise the way new drugs are developed and the way patients are cared for, through a pioneering new approach using virtual clinical trials.
Following a £500,000 Royal Academy of Engineering research funding award, Dr Himanshu Kaul, will expand research with his 'virtual asthma patient' to participate in virtual clinical trials, which could help make more accurate and timely predictions around which new drugs are successful and can offer benefits to patients.
Virtual clinical trials could also help doctors gain a better understanding of individual patients' disease progression, allowing them to tailor therapies to patients' individual needs and improve outcomes in a wider range of cases.